Mid-day market update: Crude Oil rises 3%; Immunovant (IMVT Stock) shares plummet
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFERMidway through trading Tuesday, the Dow traded up 2.02% to 30,821.97 while the NASDAQ rose 1.41% to 13,592.22. The S&P also rose, gaining 1.73% to 3,839.07.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 26,322,210 cases with around 443,610 deaths. India confirmed a total of at least 10,766,240 confirmed cases and 154,480 deaths, while Brazil reported over 9,229,320 COVID-19 cases with 225,090 deaths. In total, there were at least 103,499,060 cases of COVID-19 worldwide with over 2,240,720 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares rose 3.4% on Tuesday. Meanwhile, top gainers in the sector included TETRA Technologies, Inc. TTI 29.53%, up 28%, and Alliance Resource Partners, L.P. ARLP 8.26%, up 11%.
In trading on Tuesday, real estate shares rose by just 0.3%.
Top Headline
Pfizer Inc. PFE 3% reported better-than-expected earnings for its fourth quarter, while sales missed views.
Pfizer reported quarterly earnings of $0.42 per share, missing analysts’ expectations of $0.48 per share. The company posted revenue of $11.70 billion, versus estimates of $11.43 billion.
Pfizer raised its FY21 adjusted EPS guidance from $3.00-$3.10 to $3.10-$3.20.
Equities Trading UP
Moleculin Biotech, Inc. MBRX 34.47% shares shot up 42% to $6.68 after the company announced 100% survival was achieved in osteosarcoma lunch metastases animal model.
Shares of Cassava Sciences, Inc.. SAVA 127.51% got a boost, shooting 80% to $41.35 after the company announced results of an interim analysis from an open-label study of simufilam, its lead drug candidate for the treatment of Alzheimer's disease. The company said "patients' cognition and behavior scores both improved following six months of simufilam treatment, with no safety issues."
American Resources Corp AREC 50.2% shares were also up, gaining 46% to $3.66 as the company acquired exclusive rights to Pursue University's rare earth element innovations, critical for clean energy technologies.
Check out these big movers of the day
Equities Trading DOWN
GameStop Corp. GME 47.83% shares tumbled 51% to $110.84 after declining around 31% on Monday. The stock has been increasingly volatile following interest from retail investors.
Shares of Immunovant Inc IMVT 43.42% were down 45% to $23.94 after the company announced a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401. The decision follows the unearthing of a physiological signal consisting of elevated total cholesterol and LDL levels in IMVT-1401-treated patients in a Phase 2b trial in thyroid eye disease.
AMC Entertainment Holdings, Inc. AMC 39.04% was down, falling 41% to $7.90. The stock has been increasingly volatile following interest from retail investors.
Commodities
In commodity news, oil traded up 3% to $55.14, while gold traded down 1.5% to $1,835.30.
Silver traded down 8.5% Tuesday to $26.915 while copper fell 0.6% to $3.5250.
Euro zone
European shares were higher today. The eurozone’s STOXX 600 gained 1.26%, the Spanish Ibex Index rose 1.96% and the German DAX 30 gained 1.5%. Meanwhile, the French CAC 40 climbed 1.94%, London’s FTSE 100 rose 0.74% and Italy’s FTSE MIB surged 1.09%.
The Eurozone economy shrank 0.7% on quarter during the final three months of 2020. Annual inflation rate in France rose to 0.6% in January, while UK’s annual house price growth slowed to 6.4% in January.
Economics
Federal Reserve Bank of Dallas President Robert Kaplan is set to speak at 1:00 p.m. ET.
Federal Reserve Bank of Cleveland President Loretta Mester will speak at 2:00 p.m. ET.
Federal Reserve Bank of New York President John Williams is set to speak at 2:00 p.m. ET.
Midway through trading Tuesday, the Dow traded up 2.02% to 30,821.97 while the NASDAQ rose 1.41% to 13,592.22. The S&P also rose, gaining 1.73% to 3,839.07.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 26,322,210 cases with around 443,610 deaths. India confirmed a total of at least 10,766,240 confirmed cases and 154,480 deaths, while Brazil reported over 9,229,320 COVID-19 cases with 225,090 deaths. In total, there were at least 103,499,060 cases of COVID-19 worldwide with over 2,240,720 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares rose 3.4% on Tuesday. Meanwhile, top gainers in the sector included TETRA Technologies, Inc. TTI 29.53%, up 28%, and Alliance Resource Partners, L.P. ARLP 8.26%, up 11%.
In trading on Tuesday, real estate shares rose by just 0.3%.
Top Headline
Pfizer Inc. PFE 3% reported better-than-expected earnings for its fourth quarter, while sales missed views.
Pfizer reported quarterly earnings of $0.42 per share, missing analysts’ expectations of $0.48 per share. The company posted revenue of $11.70 billion, versus estimates of $11.43 billion.
Pfizer raised its FY21 adjusted EPS guidance from $3.00-$3.10 to $3.10-$3.20.
Equities Trading UP
Moleculin Biotech, Inc. MBRX 34.47% shares shot up 42% to $6.68 after the company announced 100% survival was achieved in osteosarcoma lunch metastases animal model.
Shares of Cassava Sciences, Inc.. SAVA 127.51% got a boost, shooting 80% to $41.35 after the company announced results of an interim analysis from an open-label study of simufilam, its lead drug candidate for the treatment of Alzheimer's disease. The company said "patients' cognition and behavior scores both improved following six months of simufilam treatment, with no safety issues."
American Resources Corp AREC 50.2% shares were also up, gaining 46% to $3.66 as the company acquired exclusive rights to Pursue University's rare earth element innovations, critical for clean energy technologies.
Check out these big movers of the day
Equities Trading DOWN
GameStop Corp. GME 47.83% shares tumbled 51% to $110.84 after declining around 31% on Monday. The stock has been increasingly volatile following interest from retail investors.
Shares of Immunovant Inc IMVT 43.42% were down 45% to $23.94 after the company announced a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401. The decision follows the unearthing of a physiological signal consisting of elevated total cholesterol and LDL levels in IMVT-1401-treated patients in a Phase 2b trial in thyroid eye disease.
AMC Entertainment Holdings, Inc. AMC 39.04% was down, falling 41% to $7.90. The stock has been increasingly volatile following interest from retail investors.
Commodities
In commodity news, oil traded up 3% to $55.14, while gold traded down 1.5% to $1,835.30.
Silver traded down 8.5% Tuesday to $26.915 while copper fell 0.6% to $3.5250.
Euro zone
European shares were higher today. The eurozone’s STOXX 600 gained 1.26%, the Spanish Ibex Index rose 1.96% and the German DAX 30 gained 1.5%. Meanwhile, the French CAC 40 climbed 1.94%, London’s FTSE 100 rose 0.74% and Italy’s FTSE MIB surged 1.09%.
The Eurozone economy shrank 0.7% on quarter during the final three months of 2020. Annual inflation rate in France rose to 0.6% in January, while UK’s annual house price growth slowed to 6.4% in January.
Economics
Federal Reserve Bank of Dallas President Robert Kaplan is set to speak at 1:00 p.m. ET.
Federal Reserve Bank of Cleveland President Loretta Mester will speak at 2:00 p.m. ET.
Federal Reserve Bank of New York President John Williams is set to speak at 2:00 p.m. ET.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.